sglt2 vs glp 1 vs dpp4 GLP-1 analogues and DPP-4 inhibitors in type 2 diabetes therapy: from structural biology to clinics The Role of DPP-4 Inhibitors
Description
Read real experiences from other users before you buy.
US pharma giant Pfizer presented detailed results from multiple Phase IIb studies of berobenatide (PF-3944), an investigational, potential first-in-class monthly GLP-1 receptor agonist (GLP-1 RA) peptide, during a late-breaking expert symposium at the 86th Scientific Sessions of the American Diabetes Association (ADA).
Across studies, fat mass decline predominated, whereas reductions in lean body mass were modest
Daily insulin users: every 2-4 weeks
